PromoCell’s mesenchymal stem cell culture portfolio wins 2020 Bioz Rising Star Award
PromoCell has been selected as a 2020 Bioz Stars Award Winner in the category “Stem Cells”
Bioz Stars Awards recognize companies that manufacture and supply high quality scientific products for life science research. Award recipients are recognized for their contribution to the life science research community. Through innovation and knowledge sharing,…
Go To Page
Our mesenchymal stem cell culture portfolio wins Bioz Rising Star Award – once again
We’re excited to announce that we’ve been selected as a 2022 Bioz Stars Award winner in the category “Stem Cells”….
Go To Page
Mesenchymal Stem Cells: Challenges and chances in cancer therapy
As the potential for using mesenchymal stem cells in cancer therapy grows, understanding the biology behind them can help inform and inspire innovative cancer therapies. Using high quality media and culture kits will increase the efficiency and usability of these highly demanded cells.
…
Go To Page
Some human mesenchymal stem cells are more equal than others – origins and differences
It is a scientific success story that started approximately 40 years ago – and was initially met with skepticism. Although the pioneers of mesenchymal stem cell research were initially criticized, today thousands of publications and hundreds of clinical trials focus on multipotent cells. New MSC research is suggesting that in the end,…
Go To Page
Endothelial to mesenchymal transition: Beyond blood vessels
Endothelial to mesenchymal transition (EndMT) is a complex biological process that is essential for various physiological functions, from embryonic development to tissue repair.1 But what happens when the mechanisms underlying EndMT are deregulated? In this article, we explore the intricacies of EndMT, discussing its mechanisms, role in health and disease, and therapeutic potential….
Go To Page
PromoCell announces services for large-scale industrial lots of Mesenchymal Stem Cells
– New services for large-scale industrial lots allows customers to have high volumes of standardized MSC populations derived from bone marrow and adipose tissue
– Guaranteed MSC functionality and phenotype in accordance to ISCT* guidelines
– Optimized media with complete supplementation and expert technical support…
Go To Page
Optimizing cryopreservation: Serum-free cell freezing medium
Cryopreservation is an integral part of biomedical research and clinical applications. However, maintaining cell viability and function during freezing and thawing can be challenging. Serum-free cryopreservation media formulations are advanced solutions that can be used instead of serum-containing freezing media to maintain cell function while ensuring reproducibility and standardization — read on to learn why….
Go To Page
Why you should know your human mesenchymal stem cells inside out
Doctors, and patients with chronic diseases, are putting hope into new findings in regenerative medicine that are based on mesenchymal stem cell (MSC) research. As promising as some published results sound, they might be not reproducible – simply due to insufficient authentication and poor handling of cell cultures. Rigorous validation of cell identity is crucial for working with human mesenchymal stem cells – and,…
Go To Page
The importance of MSC characterization
Characterization of mesenchymal stem cells (MSCs) is vital for their successful application in regenerative medicine. These multipotent cells can differentiate into several cell types, making them a promising therapeutic option for various diseases. In our blog post, we discuss the importance of MSC characterization in ensuring standardized and reproducible cell isolation,…
Go To Page
Mesenchymal stem cells: why optimizing manufacturing processes is key for a successful application
Mesenchymal stem cells (MSCs) are the up-and-coming stars of cell therapy. They are able to differentiate, are very adaptable and can reduce inflammation, making them ideal for regenerative medicine approaches. But the demand for MSCs is far greater than supply. Pharmaceutical companies are racing to produce commercial-scale quantities of MSCs while guaranteeing quality standards….
Go To Page
Growing stem cells in space – PromoCell aboard the International Space Station
In March 2020, two researchers at the University of Zurich (UZH) Space Hub, Professor Oliver Ullrich and Dr. Cora Thiel, sent human stem cells to space to determine if they could develop into three-dimensional organoids. Three years later, the results of this and a subsequent experiment demonstrate that culturing stem cells in space is possible,…
Go To Page
Stem cell immunotherapy: Harnessing the immune system
Imagine a future where diseases once considered incurable are now within reach of treatment. This is the promise of stem cell immunotherapy, a rapidly evolving approach that harnesses the unique properties of pluripotent cells to revolutionize medical treatments.1 From autoimmune diseases to cancer, the potential of stem cell immunotherapy is vast and transformative. …
Go To Page